BIO Sep 2024 270.000 call
| Previous close | 38.40 |
| Open | 31.20 |
| Bid | 29.00 |
| Ask | 38.10 |
| Strike | 270.00 |
| Expiry date | 2024-09-20 |
| Day's range | 31.20 - 31.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
Business WireBio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
HERCULES, Calif., May 30, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024.
Business WireBio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
HERCULES, Calif., May 23, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).
